Compare Merck & Co., Inc. (MRK) vs Energy Select Sector SPDR Fund (XLE) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Merck & Co., Inc. vs Energy Select Sector SPDR Fund — how do they compare? Merck & Co., Inc. trades at $126.26 (market cap $307.25B), while Energy Select Sector SPDR Fund trades at $58.54. The key difference: Merck & Co., Inc. pays a 2.73% dividend while Energy Select Sector SPDR Fund pays none, and Merck & Co., Inc. is trading nearer its 52-week high, Energy Select Sector SPDR Fund nearer its low. Which is the better fit depends on your goals.
| MRK | XLE | |
|---|---|---|
Market Cap | $307.25B | — |
Sector | Health | — |
52-Week High | $129.52 | $62.57 |
52-Week Low | $77.60 | $42.12 |
Enterprise Value | $350.66B | — |
Dividend Yield | 2.73% | — |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Merck (MRK) trades at $126.27, down 0.96% on the day, with a neutral technical signal and strong fundamental performance. The company reported robust 2025 results with $65.01B revenue and $18.25B net income, beating EPS estimates in recent quarters. Recent news highlights Merck's acquisition of Terns Pharmaceuticals to bolster its oncology pipeline, while analyst consensus remains bullish with a $137.30 price target.
Outlook is positive driven by earnings momentum and strategic M&A, but risks include patent expirations and competitive pressures. The stock offers a dividend yield with upcoming payment, supporting income investors. Valuation multiples are elevated, requiring sustained growth to justify current levels amid macroeconomic uncertainties.
XLE trades at $57.96, up 0.49% today, with a bullish technical signal supported by moving averages but showing overbought RSI readings. The ETF maintains a low 0.08% expense ratio and focuses on S&P 500 energy giants. Recent news highlights XLE's competitive advantages in liquidity and cost structure compared to energy infrastructure ETFs.
Outlook remains positive given elevated oil prices and strong sector earnings growth expectations, though overbought conditions and geopolitical risks warrant caution. The ETF's concentration in major energy companies provides stable exposure to traditional energy sector performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Merck & Co., Inc.
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent hepatitis B and pediatric diseases as well as HPV and shingles. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the firm's sales are generated in the United States.
Read more on MRK →About Energy Select Sector SPDR Fund
In seeking to track the performance of the index, the fund employs a replication strategy. It generally invests substantially all, but at least 95%, of its total assets in the securities comprising the index. The index includes companies that have been identified as energy companies by the GICS®, including securities of companies from the following industries: oil, gas and consumable fuels; and energy equipment and services. It is non-diversified.
Read more on XLE →
